Financial Year 2013 has been one of continued growth
and maturation for Nanosonics, highlighted by a number of
achievements, including:
-
Increased sales driven mainly by sales to our key
North American market;
-
Sales growth in the US strongly supported by
Nanosonics’ US sales team;
-
Hiring of a highly experienced team to drive sales in the
key European markets;
-
Forging new and deeper relationships with our major
distribution partners;
-
A significant increase in the number of ultrasound
probes that are certified for use with our technology,
and broadened our patent portfolio;
-
Progress towards regulatory approval in new markets
including Japan, South Korea and Mexico;
-
Continued and growing awareness of our technology,
with healthcare facilities and regulators who are
increasingly alert to the issue of healthcare acquired
infection (HAIs); and
-
Growing evidence of risks associated with TGA/FDA
approved liquid disinfection procedures.
No comments:
Post a Comment